FDA
approval
· 2020-08-20
FDA Approved: CAPTOPRIL AND HYDROCHLOROTHIAZIDE — Supplemental Application (Rising Pharma Holdings, Inc.)
Summary
The FDA approved a supplemental (ANDA) application for a generic captopril and hydrochlorothiazide combination tablet submitted by Rising Pharma Holdings, Inc.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for CAPTOPRIL AND HYDROCHLOROTHIAZIDE (CAPTOPRIL AND HYDROCHLOROTHIAZIDE)